Manuel Daldin, Scientist – High Throughput Biology and Screening and Heidi Kingdon Jones, Global VP Business Development are attending the Biomarker conference in Manchester. Manuel will be presenting on the “development and validation of an assay to detect mutant huntingtin protein for the assessment of pharmacodynamic effects in human and rodent samples”.

Please get in contact if you’ll be there too and would like to arrange a meeting to discuss our exceptional biomarker and drug discovery services bd@irbm.com